DLN-0500

N/A

Report date: 2025/01/26 19:12:39
NME

Base Information

Drug NameDLN-0500
Drug Alias Nameoligonucleotide therapy (University of Sheffield)oligonucleotide therapy (Diurnal)DLN-0500
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPituitary ACTH Hypersecretion
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesEuropeUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Sheffield
China Registration ClassN/A

Develop Information

Active CompaniesDiurnal Ltd
Inactive CompaniesN/A
Active IndicationsPituitary ACTH Hypersecretion
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A